Literature DB >> 6710339

Polymerized pyridoxylated hemoglobin: a red cell substitute with normal oxygen capacity.

L R Sehgal, S A Gould, A L Rosen, H L Sehgal, G S Moss.   

Abstract

Polymerization of pyridoxylated stroma free hemoglobin (poly SFH-P) yields a solution with a normal hemoglobin concentration, normal colloid osmotic pressure (COP), and a suitable P50. In the present study we compared its in vivo O2-carrying capacity and intravascular persistence with those of pyridoxylated hemoglobin (SFH-P), following a partial exchange transfusion (900 ml) in adult baboons (n = 4 in each group). Poly SFH-P in plasma had an O2-carrying capacity that was 77% greater than that achieved with SFH-P (8.0 versus 4.5 vol%). Furthermore, poly SFH-P provided 5.0 vol% at the end of 24 hours and 2.5 vol% at the end of 48 hours; in contrast SFH-P provided only 2.2 vol% at the end of 6 hours and none within 24 hours. A normal COP was maintained throughout the postexchange period with poly SFH-P despite a 68% increase in plasma protein concentration (from 7.1 to 11.9 gm/dl). The plasma P50 of poly SFH-P decreased from 16 torr immediately after exchange to 12 torr at the end of 48 hours. The in vivo rate of conversion to methemoglobin was similar with both solutions. Polymerized pyridoxylated hemoglobin is currently the only modification of hemoglobin solution that approximates the O2-carrying capacity of whole blood and can be infused without altering the plasma COP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6710339

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

Review 1.  Blood transfusion: yesterday, today, and tomorrow.

Authors:  W J Rudowski
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

Review 2.  Red cell substitutes: present status.

Authors:  L R Sehgal; H L Sehgal; S A Gould; A L Rosen; R DeWoskin; G S Moss
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

3.  Modulation of oxidative stability of haemoglobin inside liposome-encapsulated haemoglobin.

Authors:  Vibhudutta Awasthi; Vivek R Yadav; Beth Goins; William T Phillips
Journal:  J Microencapsul       Date:  2012-12-11       Impact factor: 3.142

4.  Preparation, properties, and plasma retention of human hemoglobin derivatives: comparison of uncrosslinked carboxymethylated hemoglobin with crosslinked tetrameric hemoglobin.

Authors:  L R Manning; S Morgan; R C Beavis; B T Chait; J M Manning; J R Hess; M Cross; D L Currell; M A Marini; R M Winslow
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Comprehensive characterization of tense and relaxed quaternary state glutaraldehyde polymerized bovine hemoglobin as a function of cross-link density.

Authors:  Xiangming Gu; Crystal Bolden-Rush; Clayton T Cuddington; Donald A Belcher; Chintan Savla; Ivan S Pires; Andre F Palmer
Journal:  Biotechnol Bioeng       Date:  2020-06-12       Impact factor: 4.530

6.  Oxygen-binding heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.

Authors:  M Zouhair Atassi; Catherine Childress
Journal:  Protein J       Date:  2005-01       Impact factor: 2.371

7.  Immunogenicity of heme complexes of peptides designed to mimic the heme environment of myoglobin and hemoglobin.

Authors:  M Zouhair Atassi; Catherine Childress
Journal:  Protein J       Date:  2005-01       Impact factor: 2.371

8.  HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.

Authors:  S R Snyder; E V Welty; R Y Walder; L A Williams; J A Walder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

9.  Autoxidation and oxygen binding properties of recombinant hemoglobins with substitutions at the αVal-62 or βVal-67 position of the distal heme pocket.

Authors:  Ming F Tam; Natalie W Rice; David H Maillett; Virgil Simplaceanu; Nancy T Ho; Tsuey Chyi S Tam; Tong-Jian Shen; Chien Ho
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

10.  The USA Multicenter Prehosptial Hemoglobin-based Oxygen Carrier Resuscitation Trial: scientific rationale, study design, and results.

Authors:  Ernest E Moore; Jeffrey L Johnson; Frederick A Moore; Hunter B Moore
Journal:  Crit Care Clin       Date:  2009-04       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.